{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:21:40Z","timestamp":1783120900969,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007523","name":"Division of Advanced Cyberinfrastructure","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007523","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.wneu.2020.04.087","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T11:46:25Z","timestamp":1587469585000},"page":"226-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab\/Nivolumab and Brain-Directed Stereotactic Radiation Therapy"],"prefix":"10.1016","volume":"139","author":[{"given":"Diana D.","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Arnaout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya L.","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth I.","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel N.","family":"Cagney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Insco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Schoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal A.","family":"Aizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2020.04.087_bib1","first-page":"4655","article-title":"Recent trends in epidemiology of brain metastases: an overview","volume":"32","author":"Tabouret","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.wneu.2020.04.087_bib2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-9966-30-10","article-title":"Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center","volume":"30","author":"Fabi","year":"2011","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.wneu.2020.04.087_bib3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jocn.2010.03.046","article-title":"Surgical treatment for brain metastases: prognostic factors and survival in 309 patients with regard to patient age","volume":"18","author":"Stark","year":"2011","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2020.04.087_bib4","author":"Ott"},{"key":"10.1016\/j.wneu.2020.04.087_bib5","first-page":"170","article-title":"Brain metastases from malignant melanoma","volume":"13","author":"Chiarion-Sileni","year":"2003","journal-title":"Forum (Genova)"},{"key":"10.1016\/j.wneu.2020.04.087_bib6","first-page":"11","article-title":"Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma","volume":"88","author":"Sampson","year":"1998","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2020.04.087_bib7","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1200\/JCO.2004.08.140","article-title":"Determinants of outcome in melanoma patients with cerebral metastases","volume":"22","author":"Fife","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastases","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.04.087_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejca.2017.01.007","article-title":"Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies","volume":"75","author":"Choong","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2020.04.087_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cncr.30946","article-title":"Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies","volume":"124","author":"Sloot","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.04.087_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejca.2017.07.017","article-title":"Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery","volume":"84","author":"Gaudy-Marqueste","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.wneu.2020.04.087_bib12","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.04.087_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib14","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1056\/NEJMoa1210093","article-title":"Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations","volume":"367","author":"Flaherty","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.04.087_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJMoa1112302","article-title":"Survival in BRAF V600\u2013mutant advanced melanoma treated with vemurafenib","volume":"366","author":"Sosman","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.04.087_bib16","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.04.087_bib17","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2020.04.087_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaoncol.2017.3993","article-title":"Immunotherapy and symptomatic radiation necrosis in patients with brain metastases treated with stereotactic radiation","volume":"4","author":"Martin","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/B:NEON.0000024744.16031.e9","article-title":"Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging","volume":"68","author":"McPherson","year":"2004","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(95)02106-X","article-title":"Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05)","volume":"34","author":"Shaw","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2020.04.087_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fonc.2018.00395","article-title":"Diagnosis and management of radiation necrosis in patients with brain metastases","volume":"8","author":"Vellayappan","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib22","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s40425-019-0805-8","article-title":"Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors","volume":"7","author":"Das","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"15 suppl","key":"10.1016\/j.wneu.2020.04.087_bib23","doi-asserted-by":"crossref","first-page":"e14534","DOI":"10.1200\/JCO.2016.34.15_suppl.e14534","article-title":"Toxicities in immunotherapy: can they predict response?","volume":"34","author":"Prior","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib24","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.ijrobp.2009.12.061","article-title":"Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the CNS","volume":"79","author":"Levin","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2020.04.087_bib25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ijrobp.2018.04.068","article-title":"Bevacizumab monotherapy reduces radiation-induced brain necrosis in nasopharyngeal carcinoma patients: a randomized controlled trial","volume":"101","author":"Xu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.wneu.2020.04.087_bib26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/(SICI)1097-0142(19971115)80:10<2005::AID-CNCR19>3.0.CO;2-0","article-title":"Hyperbaric oxygen therapy for radiation-induced brain injury in children","volume":"80","author":"Chuba","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2020.04.087_bib27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-510X(03)00007-8","article-title":"Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy","volume":"209","author":"Kohshi","year":"2003","journal-title":"J\u00a0Neurol Sci"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2020.04.087_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000056426","article-title":"Treatment of cerebral radionecrosis by hyperbaric oxygen therapy","volume":"70","author":"Leber","year":"1998","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.wneu.2020.04.087_bib29","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1212\/WNL.44.11.2020","article-title":"Treatment of radiation-induced nervous system injury with heparin and warfarin","volume":"44","author":"Glantz","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2020.04.087_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000338251","article-title":"Laser interstitial thermal therapy for focal cerebral radiation necrosis: a case report and literature review","volume":"90","author":"Rahmathulla","year":"2012","journal-title":"Stereotact Funct Neurosurg"},{"key":"10.1016\/j.wneu.2020.04.087_bib31","first-page":"804","article-title":"Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis","volume":"130","author":"Ahluwalia","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2020.04.087_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13014-015-0525-2","article-title":"Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases","volume":"10","author":"Lischalk","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.wneu.2020.04.087_bib33","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.ijrobp.2016.03.013","article-title":"Single-fraction versus multifraction (3\u00a0\u00d7 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis","volume":"95","author":"Minniti","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020307944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875020307944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:49:06Z","timestamp":1761814146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875020307944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":33,"alternative-id":["S1878875020307944"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2020.04.087","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab\/Nivolumab and Brain-Directed Stereotactic Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2020.04.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}